Abstract:Objective To investigate the risk factors for non－neoplastic portal vein thrombosis（PVT）in patients with liver cirrhosis and related early predictive factors. Methods A total of 50 cirrhotic patients with non－neoplastic PVT who were hospitalized and treated in Department of Hepatology，The Second Hospital of Lanzhou University，from July 1，2021 to June 30，2022 were enrolled as PVT group，and 100 cirrhotic patients without PVT who were treated during the same period of time were randomly selected as control group. Related clinical data were collected. The independent－samples t test was used for comparison of normally distributed continuous data between two groups，and the Mann－Whitney U test was used for comparison of non－normally distributed continuous data between two groups；the chi－square test was used for comparison of categorical data between two groups. A multivariate Logistic regression model analysis was used to investigate the influencing factors for PVT in liver cirrhosis，and the receiver operating characteristic curve was used to evaluate the predictive performance of influencing factors. Results The univariate analysis showed that there were no significant differences between the two groups in the indicators such as protein C，protein S，prothrombin time，international standardized ratio，fibrinogen，white blood cell count，platelet count，and biochemical parameters（all P>0.05），while there were significant differences between the two groups in history of splenectomy，history of endoscopic treatment of esophageal and gastric varices，history of hepatic encephalopathy，administration of non－selective β－blocker（NSBB）， D－dimer， hemoglobin，and triglyceride（all P<0.05）. The multivariate Logistic regression model analysis showed that D－dimer（odds ratio［OR］＝1.120，95% confidence interval［CI］： 1.006－1.246，P＝0.038），history of splenectomy（OR＝9.320，95% CI：2.928－29.665，P<0.001）， history of hepatic encephalopathy（OR＝16.813，95% CI：1.808－156.336，P＝0.013）， and administration of NSBB（OR＝3.203，95% CI：1.020－10.051，P＝0.046） were independent risk factors for PVT. Conclusion Elevated D－dimer，history of splenectomy，history of hepatic encephalopathy，and administration of NSBB are predictive factors for non－neoplastic PVT in patients with liver cirrhosis.

Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study

A Single Hospital Study on Portal Vein Thrombosis in Cirrhotic Patients - Clinical Characteristics & Risk Factors.

Prevalence and Clinical Significance of Portal Vein Thrombosis in Cirrhotic Patients with Acute Decompensation

Clinical characteristics and predictors of benign portal vein thrombosis in patients with liver cirrhosis: A retrospective single-center study

Novel insights into the development of portal vein thrombosis in cirrhosis patients

Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: Results of a longitudinal study

Occlusive Portal Vein Thrombosis As A New Marker of Decompensated Cirrhosis

Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation

Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study

Risk Factors of Portal Vein Thrombosis after Devascularization Treatment in Patients with Liver Cirrhosis: A Nested Case-Control Study

Predicting the risk of variceal rehemorrhage in cirrhotic patients with portal vein thrombosis: A two-center retrospective study

Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis.

Increased Portal Vein Diameter is Predictive of Portal Vein Thrombosis Development in Patients with Liver Cirrhosis

Portal Vein Thrombosis Can Aggravate Esophageal Variceal Bleeding After Endoscopic Variceal Ligation

Portal vein thrombosis in patients with liver cirrhosis

Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies

Risk factors of portal venous thrombosis development in patients with portal hypertension

Safety, Efficacy and Prognosis of Anticoagulant Therapy for Portal Vein Thrombosis in Cirrhosis: a Retrospective Cohort Study

Association of nonmalignant portal vein thrombosis and clinical outcomes in patients with cirrhosis and acute variceal bleeding: a multicenter observational study

Risk factors for non-neoplastic portal vein thrombosis in patients with liver cirrhosis

Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes